• Molecular NameNovobiocin
  • SynonymAntibiotic Pa-93; Crystallinic Acid; NOV; Novobiocina [INN-Spanish]; Novobiocine [INN-French]; Novobiocinum [INN-Latin]
  • Weight612.632
  • Drugbank_IDDB01051
  • ACS_NO303-81-1
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)2.15
  • pkaN/A
  • LogD (pH=7, predicted)-0.5
  • Solubility (experiment)Insoluble
  • LogS (predicted, ACD/Labs)(ph=7)-1.74
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.07
  • No.of HBond Donors6
  • No.of HBond Acceptors13
  • No.of Rotatable Bonds9
  • TPSA196.1
  • StatusFDA approved
  • AdministrationIntravenous
  • PharmacologyAn aminocoumarin antibiotic that is produced by the actinomycete Streptomyces niveus, which has recently been identified as a subjective synonym for S. spheroides
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability0.0
  • Protein binding95.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmExcreted unchanged
  • Half lifeN/A
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A